Nr. 1, 2008 - Romanian Journal of Cardiology
Nr. 1, 2008 - Romanian Journal of Cardiology
Nr. 1, 2008 - Romanian Journal of Cardiology
- No tags were found...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Ghid de diagnostic şi tratament al sindroamelor coronariene acute<br />
fără supradenivelare de segment ST<br />
10. ABREVIERI<br />
ACC<br />
ACE inhibitors<br />
ACS<br />
ACT<br />
ADP<br />
AHA<br />
aPTT<br />
ARB<br />
A-V<br />
BMS<br />
(American College <strong>of</strong> <strong>Cardiology</strong>)<br />
(Angiotensin-converting enzyme inhibi tors)<br />
(Acute coronary syndrome)<br />
(Activated clotting time)<br />
(Adenosine diphosphate)<br />
(American Heart Association)<br />
(Activated partial thromboplastin time)<br />
(Angiotensin receptor blocker)<br />
(Atrioventricular)<br />
(Bare metal stent)<br />
BNP<br />
(Brain natriuretic peptide)<br />
CABG (Coronary bypass graft surgery)<br />
CAD<br />
(Coronary artery disease)<br />
CARDS (<strong>Cardiology</strong> Audit and Registration Data Standards)<br />
CCS<br />
(Canadian Cardiovascular Society)<br />
CI<br />
(Confidence interval)<br />
CIN<br />
(Contrast-induced nephropathy)<br />
CK<br />
(Creatinine kinase)<br />
CKD<br />
(Chronic kidney disease)<br />
CK-MB (Creatinine kinase myocardial band)<br />
COX<br />
(Cyclo-oxygenase)<br />
CPG<br />
(Committee for Practice Guidelines)<br />
CrCl<br />
(Creatinine clearance)<br />
CT<br />
(Computed tomography)<br />
cTnTor cTnI (Cardiac troponin Tor cardiac troponin I)<br />
DES<br />
(Drug-eluting stent)<br />
dL<br />
(decilitre)<br />
DPG<br />
(Diphosphoglyceric)<br />
DTI<br />
(Direct thrombin inhibitor)<br />
DVT<br />
(Deep vein thrombosis)<br />
e.g.<br />
(for example)<br />
ECG<br />
(Electrocardiogram)<br />
EDTA (Ethylenediamine triacetic acid)<br />
EF<br />
(Ejection fraction)<br />
ESC<br />
(European Society <strong>of</strong> <strong>Cardiology</strong>)<br />
EU<br />
(European Union)<br />
Factor-Xa (Activated factor-X)<br />
GFR<br />
(Glomerular filtration rate)<br />
GPIIb/IIIa (Glypoprotein IIb/IIIa inhibitors)<br />
inhibitors<br />
Hct<br />
(Haematocrit)<br />
HDL<br />
(High-density lipoprotein)<br />
HIT<br />
(Heparin-induced thrombocytopenia)<br />
HR<br />
(Hazard ratio)<br />
hsCRP (High-sensitive C-reactive protein)<br />
i.e.<br />
(that is)<br />
INR<br />
(International normalized ratio)<br />
IU<br />
(International units)<br />
kg<br />
(kilogram)<br />
LBBB<br />
(Left-bundle branch block)<br />
LDL<br />
(Low-density lipoprotein)<br />
LMWH (Low molecular weight heparin)<br />
LV<br />
(Left ventricular)<br />
LVEF<br />
(Left ventricular ejection fraction)<br />
MB<br />
(Myocardial band)<br />
MDRD (Modification <strong>of</strong> Diet in Renal Disease)<br />
METS (Metabolic equivalents)<br />
mg<br />
(milligram)<br />
Revista Română de Cardiologie<br />
Vol. XXIII, <strong>Nr</strong>. 1, <strong>2008</strong><br />
MI<br />
(Myocardial infarction)<br />
mL<br />
(millilitre)<br />
mm<br />
(millimetre)<br />
MPO<br />
(Myeloperoxidase)<br />
MRI<br />
(Magnetic resonance imaging)<br />
mV<br />
(millivolt)<br />
NNT<br />
(Numbers needed to treat)<br />
NSAID (Non-steroidal anti-inflammatory drug)<br />
NSTE-ACS (Non-ST-elevation acute coronary syndromes)<br />
NSTEMI (Non-ST elevation myocardial infarction)<br />
NT-proBNP (N-terminal pro-hormone brain natriuretic peptide)<br />
OR<br />
(Odds ratio)<br />
PCI<br />
(Percutaneous coronary intervention)<br />
PDA<br />
(Personal digital assistant)<br />
PF4 (Platelet factor 4)<br />
RR<br />
(Risk ratio)<br />
STE-ACS (ST-elevation-acute coronary syndrome)<br />
STEMI (ST-elevation myocardial infarction)<br />
t-PA<br />
(Tissue plasminogen activator)<br />
TVR<br />
(Target vessel revascularization)<br />
UFH<br />
(Unfractionated heparin)<br />
ULN<br />
(Upper limits <strong>of</strong> normal)<br />
VKA<br />
(Vitamin K antagonist)<br />
VF<br />
(Ventricular fibrillation)<br />
VT<br />
(Ventricular tachycardia)<br />
VTE<br />
(Venous thrombo-embolism)<br />
11. ACRONIME DE TRIALURI<br />
ACUITY<br />
ACUTE-2<br />
ASPIRE<br />
BARI<br />
CAPRIE<br />
CAPTURE<br />
CARDS<br />
CHARISMA<br />
CRUSADE<br />
CURE<br />
DIGAMI<br />
EARLY-ACS<br />
ESPRIT<br />
ESSENCE<br />
FRISC<br />
FRISC-2<br />
GRACE<br />
GUSTO<br />
GUSTO-2<br />
GUSTO-4<br />
GUSTO-4-ACS<br />
(Acute Catheterization and Urgent Intervention Triage strategy)<br />
(Antithrombotic Combination Using Tir<strong>of</strong>iban and Enoxaparin)<br />
(Arixtra Study in Percutaneous Coronary Interventions)<br />
(Bypass Angioplasty Revascularisation Investigation)<br />
(Clopidogrel vs. Aspirin in Patients at Risk <strong>of</strong> Ischaemic Events)<br />
(Chimeric 7E3 Antiplatelet Therapy in Unstable Angina<br />
Refractory to Standard Treatment)<br />
(Collaborative Atorvastatin Diabetes Study)<br />
(Clopidogrel for High Atherothrombotic Risk and Ischemic<br />
Stabilization, Management and Avoidance)<br />
(Can Risk Stratification <strong>of</strong> Unstable Angina Patients Suppress<br />
Adverse Outcomes with Early Implemen tation <strong>of</strong> the ACC/AHA<br />
Guidelines)<br />
(Clopidogrel in Unstable Angina to Prevent Recur rent Events)<br />
(Diabetes Mellitus, Insulin Glucose Infusion in Acute<br />
Myocardial Infarction)<br />
(Early Glycoprotein IIb/IIIa Inhibition in patients with Non<br />
ST segment Elevation Acute Coronary Syndromes)<br />
(Enhanced Suppression <strong>of</strong> the Platelet IIb/IIIa Receptor with<br />
Integrilin Therapy)<br />
(Efficacy and Safety <strong>of</strong> Subcutaneous Enoxa parin in Non-Q<br />
Wave Coronary Events)<br />
(Fast Revascularisation during InStability in Coron ary artery<br />
disease)<br />
(Fragmin and Fast Revascularisation during InStability in<br />
Coronary artery disease II)<br />
(Global Registry <strong>of</strong> Acute Coronary Events)<br />
(Global Utilization <strong>of</strong> Streptokinase and t-PA for Occluded<br />
Coronary Arteries)<br />
(Global Use <strong>of</strong> Strategies To open Occluded coronary arteries II)<br />
(Global Utilization <strong>of</strong> Strategies To open Occluded coronary<br />
arteries IV)<br />
(Global Utilization <strong>of</strong> Strategies To open Occluded coronary<br />
arteries trial IV in Acute Coronary Syndromes)
Change language